➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
Mallinckrodt
Boehringer Ingelheim
Merck
AstraZeneca

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

Bepridil hydrochloride - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for bepridil hydrochloride and what is the scope of patent protection?

Bepridil hydrochloride is the generic ingredient in two branded drugs marketed by Medpointe Pharm Hlc and Johnson And Johnson, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for bepridil hydrochloride.

Summary for bepridil hydrochloride
Recent Clinical Trials for bepridil hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of LiverpoolPhase 1
University of Turin, ItalyPhase 1
St Stephens Aids TrustPhase 1

See all bepridil hydrochloride clinical trials

Medical Subject Heading (MeSH) Categories for bepridil hydrochloride

US Patents and Regulatory Information for bepridil hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medpointe Pharm Hlc BEPADIN bepridil hydrochloride TABLET;ORAL 019001-002 Dec 28, 1990 DISCN No No   Start Trial   Start Trial   Start Trial
Johnson And Johnson VASCOR bepridil hydrochloride TABLET;ORAL 019002-001 Dec 28, 1990 DISCN No No   Start Trial   Start Trial   Start Trial
Medpointe Pharm Hlc BEPADIN bepridil hydrochloride TABLET;ORAL 019001-003 Dec 28, 1990 DISCN No No   Start Trial   Start Trial   Start Trial
Johnson And Johnson VASCOR bepridil hydrochloride TABLET;ORAL 019002-003 Dec 28, 1990 DISCN No No   Start Trial   Start Trial   Start Trial
Medpointe Pharm Hlc BEPADIN bepridil hydrochloride TABLET;ORAL 019001-001 Dec 28, 1990 DISCN No No   Start Trial   Start Trial   Start Trial
Johnson And Johnson VASCOR bepridil hydrochloride TABLET;ORAL 019002-002 Dec 28, 1990 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for bepridil hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Medpointe Pharm Hlc BEPADIN bepridil hydrochloride TABLET;ORAL 019001-001 Dec 28, 1990   Start Trial   Start Trial
Johnson And Johnson VASCOR bepridil hydrochloride TABLET;ORAL 019002-001 Dec 28, 1990   Start Trial   Start Trial
Medpointe Pharm Hlc BEPADIN bepridil hydrochloride TABLET;ORAL 019001-003 Dec 28, 1990   Start Trial   Start Trial
Johnson And Johnson VASCOR bepridil hydrochloride TABLET;ORAL 019002-002 Dec 28, 1990   Start Trial   Start Trial
Medpointe Pharm Hlc BEPADIN bepridil hydrochloride TABLET;ORAL 019001-002 Dec 28, 1990   Start Trial   Start Trial
Johnson And Johnson VASCOR bepridil hydrochloride TABLET;ORAL 019002-003 Dec 28, 1990   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
Merck
Johnson and Johnson
Moodys
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.